BREOXA Trademark

Trademark Overview

On Wednesday, June 11, 2014, a trademark application was filed for BREOXA with the United States Patent and Trademark Office. The USPTO has given the BREOXA trademark a serial number of 86306960. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 7, 2017. This trademark is owned by Allergan, Inc.. The BREOXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of erythema associated with rosacea
breoxa

General Information

Serial Number86306960
Word MarkBREOXA
Filing DateWednesday, June 11, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 7, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of erythema associated with rosacea
Translation of Words in MarkThe word(s) "BREOXA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 21, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Monday, August 7, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 7, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 5, 2016EXTENSION 4 GRANTED
Monday, October 31, 2016EXTENSION 4 FILED
Monday, October 31, 2016TEAS EXTENSION RECEIVED
Friday, April 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2016EXTENSION 3 GRANTED
Tuesday, April 12, 2016EXTENSION 3 FILED
Tuesday, April 12, 2016TEAS EXTENSION RECEIVED
Wednesday, October 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 27, 2015EXTENSION 2 GRANTED
Thursday, October 15, 2015EXTENSION 2 FILED
Monday, October 26, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 15, 2015TEAS EXTENSION RECEIVED
Wednesday, March 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 23, 2015EXTENSION 1 GRANTED
Monday, March 23, 2015EXTENSION 1 FILED
Monday, March 23, 2015TEAS EXTENSION RECEIVED
Tuesday, January 6, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 7, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 30, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 23, 2014ASSIGNED TO LIE
Monday, September 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 20, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 20, 2014NON-FINAL ACTION E-MAILED
Saturday, September 20, 2014NON-FINAL ACTION WRITTEN
Saturday, September 20, 2014ASSIGNED TO EXAMINER
Saturday, June 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 14, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

breoxa associated rosacea erythema treatment preparation pharmaceutical